Long-term follow-up of drug-eluting stents placed in the setting of ST-segment elevation myocardial infarction

JACC Cardiovasc Interv. 2011 Jan;4(1):39-41. doi: 10.1016/j.jcin.2010.10.006.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects
  • Angioplasty, Balloon, Coronary / instrumentation*
  • Angioplasty, Balloon, Coronary / mortality
  • Cardiovascular Agents / administration & dosage*
  • Drug-Eluting Stents*
  • Evidence-Based Medicine
  • Humans
  • Metals*
  • Myocardial Infarction / mortality
  • Myocardial Infarction / therapy*
  • Paclitaxel / administration & dosage
  • Prosthesis Design
  • Recurrence
  • Risk Assessment
  • Risk Factors
  • Sirolimus / administration & dosage
  • Stents*
  • Thrombosis / etiology
  • Time Factors
  • Treatment Outcome

Substances

  • Cardiovascular Agents
  • Metals
  • Paclitaxel
  • Sirolimus